Stay updated on OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial
Sign up to get notified when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.

Latest updates to the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Record History now shows a new revision entry: v3.3.2 has been added, replacing the previous v3.3.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe record history shows an addition of Revision: v3.3.1 and a deletion of Revision: v3.2.0. These updates are administrative and do not affect study data or displayed information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding status notice at the top of the page was removed. It previously informed users about potential delays and operating status.SummaryDifference0.7%

- Check43 days agoChange DetectedThe history shows multiple versions with updates to recruitment status, study status, and study design. The version list now extends up to 2021-06-07.SummaryDifference0.1%

- Check72 days agoChange DetectedSummary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference12%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.